載入...
Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial
INTRODUCTION: Intracerebral haemorrhage (ICH) can be devastating and is a common cause of death and disability worldwide. Pre-ICH antiplatelet drug use is associated with a 27% relative increase in 1 month case fatality compared with patients not using antithrombotic drugs. We aim to assess the feas...
Na minha lista:
| 發表在: | BMJ Open |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7656949/ https://ncbi.nlm.nih.gov/pubmed/33172941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-037555 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|